"CAP Muralles"

During the past decade, CAP Muralles conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CAP Muralles" #1 collaborator was "Eurofins Optimed" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CAP Muralles" are "Cardiovascular Disease" (2 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "CAP Muralles" in a lesser frequency.

Most popular intervention types in "CAP Muralles" are "Drug" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Daily intake of study product" (1 trials). Other intervention names were less common.

The vast majority of trials in "CAP Muralles" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CAP Muralles". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CAP Muralles, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CAP Muralles, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".